Abstract
Background
One of the causes of death in patients with liver cirrhosis is hepatic encephalopathy (HE). Hyperammonemia is the most important cause of HE.
Aim
The aim of this work was to determine the relation between the Helicobacter pylori infection and minimal hepatic encephalopathy (MHE) in cirrhotic patients and to assess the outcome after treatment of H. pylori.
Patients and methods
This study was carried out on 50 Egyptian cirrhotic patients. The patients were divided into two groups: group A1 (32 positive H. pylori) and group A2 (18 negative H. pylori). Both groups were compared with 20 (age and sex matched) healthy individuals (group B). Patients and controls were subjected to an assessment of history, clinical examination, upper gastrointestinal endoscopy with gastric biopsy for histopathological examination of H. pylori, abdominal ultrasound, neuropsychiatric assessment using the figure connection test (FCT), complete blood count, liver and kidney function tests, and determination of plasma ammonia level. Plasma ammonia level and FCT were measured before and after treatment of H. pylori among patients with positive H. pylori.
Results
Plasma ammonia levels and FCT were highly significantly increased in all cirrhotic patients (group A) compared with the controls (group B) (P < 0.01) and in the positive H. pylori patients (group A1) compared with the negative H. pylori patients (group A2) (P < 0.01) and in group A1 before treatment compared with after treatment (P < 0.01).
Conclusions
There is a highly significant association between H. pylori infection and MHE in cirrhotic patients. The treatment of H. pylori infection reduces the mean plasma ammonia levels and improves FCT results among the infected patients. Therefore, H. pylori infection is an effective treatable risk factor for the clinical management of MHE.
Article PDF
Similar content being viewed by others
References
Tianzuo Z, Wolfgang S. The diagnosis and treatment of minimal hepatic encephalopathy. Dtsch Arztebl Int 2012; 109:180–187.
Prakash R, Mullen KD. Mechanisms, diagnosis and management of hepatic encephalopathy. Nat Rev Gastroenterol Hepatol 2010; 7: 515–525.
Duarte-Rojo A, Estradas J, Hernández-Ramos R, Ponce-de-León S, Córdoba J, Torre A. Validation of the psychometric hepatic encephalopathy score (PHES) for identifying patients with minimal hepatic encephalopathy. Dig Dis Sci 2011; 56:3014–3023.
Agrawal A, Gupta A, Chandra M, Koowar S. Role of Helicobacter pylori infection in the pathogenesis of minimal hepatic encephalopathy and effect of its eradication. Indian J Gastroenterol 2011; 30:29–32.
Perazzo JC, Tallis S, Delfante A, Souto PA, Lemberg A, Eizayaga FX, Romay S. Hepatic encephalopathy: an approach to its multiple pathophysiological features. World J Hepatol 2012; 4:50–65.
Montgomery JY, Bajaj JS. Advances in the evaluation and management of minimal hepatic encephalopathy. Curr Gastroenterol Rep 2011; 13:26–33.
Muzaffar A, Muhammad R, Akbar Y, Zafrullah, Roohi B, Bhuvnesh Kumar M. Frequency of Helicobacter Pylori among hepatic encephalopathic patients in liver cirrhosis. JLUMHS 2012; 11:93–96.
De Francesco V, Ierardi E, Hassan C, Zullo A. Helicobacter pylori therapy: present and future. World J Gastrointest Pharmacol Ther 2012; 3:68–73.
Morgan M, Stubbs M. Hepatic encephalopathy in patients with cirrhosis. Int J Clin Rev 2011; 02:04.
Weissenborn K. PHES: one label, different goods?. J Hepatol 2008; 49:308–312.
Agrawal A, Gupta A, Chandra M, Koowar S. Role of Helicobacter pylori infection in the pathogenesis of minimal hepatic encephalopathy and effect of its eradication. Indian J Gastroenterol 2011; 30:29–32.
Si J, Cao Q, Gao M, Fang L, Qian G, Wang Y. Changes in serum ammonia concentration in cirrhotic patients with Helicobacter pylori infection. Chin Med J (Engl) 2000; 113:1080–1081.
Jiang HX, Qin SY, Min ZG, Xie MZ, Lin T, Hu BL, Guo XY. Association of Helicobacter pylori with elevated blood ammonia levels in cirrhotic patients: a meta-analysis. Yonsei Med J 2013; 54:832–838.
Chen S, Wang L, Zhu Q, Cai J, Chen T, Si J. Effect of H. pylori infection and its eradication on hyperammonemia and hepatic encephalopathy in cirrhotic patients. World J Gastroenterol 2008; 14:1914–1918.
Huber M, Rossle M, Siegerstetter V, Ochs A, Haag K, Blum HE, et al. Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis. Hepatogastroenterology 2001; 48:541–544.
Scotiniotis I, Lucey M, Metz D. Helicobacter pylori infection is not associated with subclinical hepatic encephalopathy in stable cirrhotic patients. Dig Dis Sci 2001; 46:2744–2751.
Shanid AS, Sojan GK, Srijaya S, Premaletha N, Kattoor RV. H-pylori infection in patients with liver cirrhosis: prevalence and association with PHG. Annals of Gastronterology 2013; 26:1–6.
Batmanabane V, Kate V, Ananthakrishnan N. Prevalence of Helicobacter pylori in patients with portal hypertensive gastropathy – a study from south India. Med Sci Monit 2004; 10:133–136.
Zullo A, Hassan C, Morini S. Hepatic encephalopathy and Helicobacter pylori: a critical reappraisal. J Clin Gastroenterol 2003; 37:164–168.
Schulz C, Schütte K, Malfertheiner P. Does H. pylori eradication therapy benefit patients with hepatic encephalopathy?: systematic review. J Clin Gastroenterol 2014; 48:491–499.
Kini D, Aggarwal R, Saraswat VA, Naik SR. Role of Helicobacter pylori infection in hyperammonemia and subclinical hepatic encephalopathy in cirrhosis of liver. Indian J Gastroenterol 2001; 20:237–240.
Rekha C, Phanidhar S, Sagar AV, Revathi A, Asra WA. Role of Helicobacter pylori and hyperammonemia in subclinical hepatic encephalopathy in cirrhosis of liver. Indian J Clin Biochem 2007; 22:136–139.
Miquel J, Barcena R, Boixeda D, Fernedanz J, SanRoman AL, Martomanz-Argila C, Ramosa F. Role of Helicobacter pylori infection and its eradication in patients with subclinical hepatic encephalopathy. Eur J Gastroenterol Hepatol 2001; 13:1067–1072.
Shavakhi A, Shariatifar B, Chuloo S, Minakari M, Sami M. Effect of Helicobacter pylori eradication on hepatic encephalopathy. Hep Mon 2008; 8:121–124.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
El-seid, S.S., Attia, F.A., El-Raouf, M.A. et al. The role of Helicobacter pylori in minimal hepatic encephalopathy. Egypt J Intern Med 27, 26–31 (2015). https://doi.org/10.4103/1110-7782.155849
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.4103/1110-7782.155849